.png){kind=icon}
K
Kornelia Kotseva
H-index:51
Citation Count:1.3万
Views:0
Biography
No content for now.
Education
No content for now.
Work Experience
No content for now.
Honors & Awards
No content for now.
EUROASPIRE 1996–2026: 30 years of research into prevention of cardiovascular disease
EUROASPIRE 1996–2026：心血管疾病预防研究30年
ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey
欧洲心脏学会关于冠状动脉心脏病的预防与康复指南及当前实践：EUROASPIRE VI调查
European Heart Journal
IF35.6
Hypertension awareness, treatment, and control in coronary heart disease patients: results of the EUROASPIRE V survey conducted in 27 countries
冠心病患者的高血压知晓率、治疗率及控制率：27个国家EUROASPIRE V调查结果
Lipid Management and Cardiovascular Risk Assessment: Physician Perspectives from Seven Countries Across Five WHORegions — Insights from the INTERASPIRE Study
脂质管理及心血管风险评估：来自五个WHO区域七个国家医师的视角——INTERASPIRE研究启示
Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study
焦虑和抑郁与冠心病二级预防在六个WHO区域14个国家的相关性：INTERASPIRE研究
Residual cardiovascular risk is tracked by apolipoprotein B in coronary patients with elevated serum triglyceride levels: the ESC EORP EUROASPIRE IV survey
残余心血管风险由载脂蛋白B在血清甘油三酯水平升高的冠心病患者中进行追踪：ESC EORP EUROASPIRE IV调查
Clinica Chimica Acta
IF2.9
Prevalence and prognostic importance of chronic kidney disease in patients with coronary heart disease: results from the combined EUROASPIRE IV and V studies
慢性肾脏病在冠心病患者中的患病率及预后重要性：来自EUROASPIRE IV和V联合研究的结果
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE
心血管疾病患者Lp(a)检测与管理的医师观点：INTERASPIRE项目五个世界卫生组织区域七个国家的访谈
Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions
患者对脂蛋白(a)检测和治疗用于心血管疾病二级预防的看法：来自INTERASPIRE研究在五个世界卫生组织区域七个国家的结果
Patient-reported experiences after ASCVD hospitalisation: results from the insights from patients living with elevated cholesterol (IPEC) study
ASCVD住院后患者报告的体验：来自“居住在高胆固醇患者中的见解”（IPEC）研究的结果
Frequency of residual combined dyslipidemia and hypertriglyceridemia in patients with coronary heart disease in 13 countries across 6 WHO Regions: Results from INTERASPIRE
13个国家6个WHO区域冠心病患者中，残余性混合型高脂血症和高三酰甘油血症的患病频率：INTERASPIRE研究的结果
ATHEROSCLEROSIS
IF5.7
Effectively Communicating the Seriousness of High Cholesterol at Diagnosis to Improve Shared Decision-Making and Adherence: Findings from the Patient-Led Insights from Patients Living with Elevated Cholesterol (IPEC) Study
有效沟通高胆固醇诊断时的严重性以改善共同决策和依从性：来自患者主导的来自患有高胆固醇患者的生活见解（IPEC）研究的结果
CIRCULATION
IF38.6
Personalised care for hyperlipidaemia by tailoring shared decision-making toward patient priorities & needs: results from a patient-led study
通过针对患者优先事项和需求定制共同决策来个性化治疗高脂血症: 一项以患者为主导的研究结果
EUROPEAN HEART JOURNAL
IF35.6
